Amneal Pharmaceuticals Inc (AMRX) stock is lower by -44.49% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives AMRX stock a score of 31 out of a possible 100.
That rank is influenced by a long-term technical score of 8. AMRX's rank also includes a short-term technical score of 15. AMRX has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on AMRX!